Physician profile
Stephen Ernst
NPI 1245627462
$24,889.62
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $4,913 · 2021: $13K · 2022: $4,851 · 2023: $549 · 2024: $1,991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,076 · Food and Beverage: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,076.06 |
| Food and Beverage | $463.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Micromed INC | $8,416.96 | 2020-2021 | |
| Encore Medical, LP | $6,453.18 | 2021-2022 | |
| Fortis Surgical, LLC | $3,089.72 | 2021-2022 | |
| Stryker Corporation | $2,103.12 | 2020-2022 | |
| Shoulder Innovations, INC. | $1,990.58 | 2024 | Inset System |
| Arthrex, INC. | $1,224.00 | 2022 | |
| Medical Device Business Services, INC. | $674.97 | 2020-2021 | |
| Piedmont Plus Innovation | $388.06 | 2023 | |
| Acumed LLC | $130.14 | 2023 | Acumed |
| Integra Lifesciences Corporation | $127.78 | 2020 | |
| Axogen | $127.28 | 2020 | |
| Medtronic USA, INC. | $75.91 | 2020 | |
| Kci USA, INC. | $56.90 | 2021 | |
| Amgen INC. | $15.96 | 2023 | Evenity, Prolia |
| Exactech, INC. | $15.06 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Ernst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.